EP2463282
4-Benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.11.2008EP published:
7.8.2013EP application number:
11188373.2
EPO information:
European Patent Register
Max expiry date:
2.11.2028
Title:
4-Benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis
Timeline
Today
3.11.2008EP application
7.8.2013EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
Mogi, MunetoAddress:
Waltham, MA Massachusetts, US
Name:
Yamada, KenAddress:
Boston, MA Massachusetts, US
Name:
Yasoshima, KayoAddress:
Cambridge, MA Massachusetts, US
Name:
Kawanami, ToshioAddress:
Boston, MA Massachusetts, US
Name:
Umemura, IchiroAddress:
Azuma Tsukuba-shi, Ibaraki, JP
Name:
Iwaki, YukiAddress:
Cambridge, MA Massachusetts, US
Name:
Qin, HongboAddress:
Hanishinagun, Nagano, JP
Name:
Imase, HidetomoAddress:
Cambridge, MA Massachusetts, US
Priority
Number:
985456 PDate:
5.11.2007Country:
US
Classification
Categories:
C07D 401/12, C07D 401/14, C07D 413/14, A61K 31/5377, A61P 3/06